Literature DB >> 18211945

Methylation of CpG island promoters in uveal melanoma.

A P Moulin1, G Clément, F T Bosman, L Zografos, J Benhattar.   

Abstract

BACKGROUND: Inactivation of tumour-related genes by promoter hypermethylation is a common epigenetic event in the development of a variety of tumours. AIM: To investigate in primary uveal melanoma the status of promoter methylation of genes thought to be involved in tumour development: p16, TIMP3, RASSF1, RARB, FHIT, hTERT and APC.
METHODS: Gene promoter methylation was studied by methylation-sensitive single-strand conformation analysis and dot-blot assay in a series of 23 primary uveal melanomas. All DNA samples were obtained from paraffin-embedded formalin-fixed tissue blocks.
RESULTS: hTERT promoter methylation was found with a relatively high frequency (52%). Promoter methylation of p16, TIMP3, RASSF1, RARB, FHIT and APC was a rare event. For none of these genes did promoter methylation exceed 15% of tumour samples, and, for some genes (FHIT and APC), no methylation was found at all. Furthermore, promoter methylation was absent in 39% (9/23) of cases. In only 22% (5/23) of cases was hypermethylation of at least two promoters observed.
CONCLUSIONS: Promoter methylation of hTERT is a regular event in uveal melanoma. Hypermethylation of the other genes studied does not seem to be an essential element in the development of this tumour. As promoter methylation of APC, RASSF1 and RARB is often observed in cutaneous melanoma, these results suggest that different epigenetic events occur in the development of cutaneous and uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211945     DOI: 10.1136/bjo.2007.127035

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Eyes on DNA methylation: current evidence for DNA methylation in ocular development and disease.

Authors:  Deborah C Otteson
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-29

2.  Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.

Authors:  De-Tao Yin; Lin Wang; Jianrui Sun; Fengyan Yin; Qingtao Yan; Rulong Shen; Gang He; Jian-Xin Gao
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

Review 3.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

4.  Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

Authors:  Thomas van den Bosch; Emine Kilic; Dion Paridaens; Annelies de Klein
Journal:  Dermatol Res Pract       Date:  2010-06-06

Review 5.  Blood biomarkers for uveal melanoma.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Future Oncol       Date:  2012-02       Impact factor: 3.674

6.  EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.

Authors:  Lisa C Neumann; Andreas Weinhäusel; Stefanie Thomas; Bernhard Horsthemke; Dietmar R Lohmann; Michael Zeschnigk
Journal:  BMC Cancer       Date:  2011-08-26       Impact factor: 4.430

Review 7.  Orchestrating epigenetic roles targeting ocular tumors.

Authors:  Xuyang Wen; Linna Lu; Zhang He; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2016-02-29       Impact factor: 4.147

Review 8.  Epigenetics and Common Ophthalmic Diseases.

Authors:  Wendy Li; Ji Liu; Jennifer A Galvin
Journal:  Yale J Biol Med       Date:  2016-12-23

Review 9.  DNA Methylation and Uveal Melanoma.

Authors:  Zhi-Kun Yang; Jing-Yun Yang; Zhuo-Zai Xu; Wei-Hong Yu
Journal:  Chin Med J (Engl)       Date:  2018-04-05       Impact factor: 2.628

Review 10.  Review: Epigenetic mechanisms in ocular disease.

Authors:  Shikun He; Xiaohua Li; Nymph Chan; David R Hinton
Journal:  Mol Vis       Date:  2013-03-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.